Akeso Inc is a biopharmaceutical company based in China that discovers, develops and commercialises antibody medicines for cancer and immune-related diseases. Its pipeline centres on bispecific antibodies that combine two therapeutic targets in a single molecule, including treatments aimed at lung cancer and other solid tumours. The company carries out research, clinical development and manufacturing, and supplies its approved medicines to hospitals and patients in China while working with partners on development in other markets.
On this site Akeso Inc appears as a stock on the Hong Kong Stock Exchange (Hong Kong), code 9926, with prices in Hong Kong dollars (HKD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #1324 of 2611 on the Hong Kong Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Hong Kong yet.
TrendWeak
40/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-22.1%
From 52-week high-44.4%
MomentumWeak
31/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-15.2%
6-month return-43.8%
12-month, skipping last month-17.7%
Stability (higher is calmer)Fair
50/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)62.0%
Worst drawdown, 1 year (smaller is calmer)-45.1%
LiquidityStrong
99/100
Trades actively.
See the numbers →
Avg daily value traded1,083.79M HKD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Hong Kong when fundamentals data for this market is added. All Hong Kong stocks.
52-wk range 80.20 – 156.00Daily closes, split-adjusted
Signals
50-day average96.10
200-day average107.65
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)5.80
Technical summary
Daily
Strongly bearish
3 bullish · 1 neutral · 12 bearish
Weekly
Strongly bearish
1 bullish · 1 neutral · 10 bearish
Monthly
Bearish
2 bullish · 1 neutral · 5 bearish
Moving averages (daily)
SMA 10
97.17
Bearish
EMA 10
94.60
Bearish
SMA 20
99.81
Bearish
EMA 20
96.99
Bearish
SMA 50
96.10
Bearish
EMA 50
97.40
Bearish
SMA 100
95.40
Bearish
EMA 100
99.83
Bearish
SMA 200
107.7
Bearish
EMA 200
104.0
Bearish
Oscillators (daily)
RSI (14)
35.48
Neutral
MACD (12, 26)
-1.75
Bearish
Momentum (12)
-20.85
Bearish
Stochastic %K (14)
2.13
Bullish
Williams %R (14)
-97.87
Bullish
CCI (20)
-128.3
Bullish
Pivot points (classic, last session)
S3
71.17
S2
77.23
S1
80.57
Pivot
86.63
R1
89.97
R2
96.03
R3
99.37
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in HKD. Educational only, not financial advice.
